MetaCap

Heartflow Financial Statements

NASDAQ: HTFLHealth CareMedical/Dental InstrumentsUSD

49.74+2.11 (+4.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 49.74 0.00%

Heartflow revenue and earnings

In fiscal 2025, Heartflow generated $176.0 million in revenue, up 39.9% from fiscal 2024, its 2nd consecutive year of revenue growth. Heartflow reported a net loss of $116.8 million, compared with a loss of $96.4 million a year earlier. Gross margin was 76.8% (up from 75.1%) and operating margin -36.4%.

Diluted earnings per share came in at -$3.17. Over the last 2 fiscal years, HTFL's revenue has grown at a 42.1% compound annual rate.

Summary generated from market data by MetaCap's automated system. Methodology

Heartflow income statement (annual)

Heartflow annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31
Revenue176.03M125.81M87.17M
Revenue growth (YoY)+39.92%+44.32%—
Cost of Revenue40.84M31.36M29.12M
Gross Profit135.20M94.45M58.05M
Operating Expenses199.26M155.67M130.97M
Research & Development64.92M43.52M35.85M
Selling, General & Admin134.34M112.15M95.11M
Operating Income-64.07M-61.22M-72.91M
Interest Expense15.17M22.77M24.69M
Other Income (Expense)-52.80M-35.15M-22.19M
Pretax Income-116.87M-96.37M-95.11M
Income Tax-76.00K53.00K547.00K
Net Income-116.79M-96.43M-95.66M
Net Income growth (YoY)———
EPS (Basic)-3.17-17.98-25.32
EPS (Diluted)-3.17-17.98-25.32
Shares Outstanding (Basic)36.85M5.36M4.89M
Shares Outstanding (Diluted)36.85M5.36M4.89M
EBITDA-58.63M-55.86M-68.17M
Gross Margin76.80%75.07%66.59%
Operating Margin-36.39%-48.66%-83.64%
Net Margin-66.35%-76.65%-109.73%

This table shows 3 annual periods of Heartflow's income statement, from FY 2025 back to FY 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow HTFL's reporting calendar. What is a income statement?

More financial data